Shanghai’s SARI to Acquire NMS, an Italian Oncology Company, for $359 Million

Life Science

Kangning to Raise $30 Million in China Psychiatric Hospital IPO

Life Science

Merck Serono, WuXi AppTec and Pontifax Form Israeli Life Science Incubator

Life Science

Asieris Pharma Closes $15 Million B Round Financing

Life Science

CG Capital of Beijing to Acquire 37% of NovaBay for $28 Million

Life Science

Big tech’s spending on healthcare equity deals up 875% in 5 years: What 5 tech giants are up to

Life Science

Nanjing Legend Lands $350 Million Upfront for CAR-T Partnership with Janssen

Life Science

Yonghua Capital Leads $25 Million B Round in Taris Biomedical

Life Science

Huadong Medicine Enters $83 Million Deal for GLP-1r Diabetes Treatment

Life Science

China’s I-Mab Inks $548 Million Immunoncology Pact with Genexine

Life Science

CANbridge Files to Start China Trials of Esophageal Cancer Treatment

Life Science

Ambrx Enters $143.5 Million China Deal for Liver Cancer Treatment

Life Science

Zai Lab Pays $44 Million for China Rights to Gastric Cancer Immunotherapy

Life Science

Happy Holidays from NAI Interactive

Energy, Financial Service, Life Science, Mining, Precious Metals, Technology

BeiGene Initiates Pivotal Trial of PARP inhibitor Pamiparib (BGB-290) in China in Patients With Ovarian Cancer

Life Science